CPC A61F 9/0017 (2013.01) [A61F 2/1662 (2013.01); A61F 2002/1683 (2013.01); A61F 2230/0013 (2013.01); A61F 2250/006 (2013.01); A61F 2250/0067 (2013.01)] | 30 Claims |
1. An ophthalmic implant comprising:
an intraocular lens (IOL) comprising an anterior side, a posterior side opposite the anterior side, a lens, and at least one haptic extending outwardly from the lens, the at least one haptic comprising a first haptic extending from the lens at a first optic-haptic junction; and
at least one drug delivery device comprising a first drug delivery device comprising a pad and a fixation portion extending from the pad, the pad comprising at least one therapeutic agent contained therein, an anterior surface, a posterior surface opposite the anterior surface, and a side surface extending around the pad and between the anterior surface and the posterior surface, the first drug delivery device configured for attachment to the IOL via the fixation portion,
wherein, in an assembled state of the ophthalmic implant, the first drug delivery device is attached to the IOL and the pad overlays the first optic-haptic junction on the anterior side of the IOL.
|